Shuangni C. Yu
Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Case Report: Pyoderma gangrenosum masquerading as skin and soft tissue infection preceding myelodysplastic syndrome.
Journal: Frontiers in medicine
Published: February 09, 2026
Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 13, 2025
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.
Journal: Journal for immunotherapy of cancer
Published: June 11, 2025
Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases.
Journal: British journal of cancer
Published: November 22, 2024
Malignant mesothelioma with a novel BAP1 germline frameshift mutation treated with dual immune checkpoint inhibitors: A case report.
Journal: Oncology letters
Published: October 11, 2024
Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.
Journal: Frontiers in immunology
Published: August 17, 2024
A 16-year-old female with an intrasellar mass.
Journal: Brain pathology (Zurich, Switzerland)
Published: July 09, 2024
Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2024
Analysis on the current situation and influencing factors of residents' satisfaction with the built environment of China's Hygienic City Initiative
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: November 26, 2023
Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review.
Journal: OncoTargets and therapy
Published: July 14, 2023
The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Journal: Theranostics
Published: May 26, 2023
Last Updated: 09/26/2026